Keywords: Well-Differentiated fetal adenocarcinoma; β-catenin; CTNNB1; BRCA2; TSC2; NGS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: EMT; epithelial mesenchymal transition; qRT-PCR; quantitative real time polymerase chain reaction; CXCL12; C-X-C motif chemokine ligand 12; CXCR4; C-X-C chemokine receptor type 4; CK7; cytokeratin-7; CDH1; E-cadherin; CLDN4; claudin-4; HIF-1A; hypoxia ind
Keywords: A.U.; Arbitrary units; BEBM; Bronchial epithelial cell basal medium; BEGM; Bronchial epithelial cell growth medium; BIF; Biological impact factor; CCL5; Chemokine (C-C motif) ligand 5; CDH1; Cadherin-1; CFA; Cell fate network; CIM; Cell invasion migration
Keywords: Aldosterone; Chimera; CYP11B1; CYP11B2; KCNJ5; ATP1A1; ATP2B3; CACNA1D; CACNA1H; CTNNB1;
Keywords: Immune Checkpoint; Virtual Microdissection; Molecular Subgroups; Immune Regulation; CCL; chemokine (C-C motif) ligand; CTNNB1; catenin beta 1; CXCL; chemokine (C-X-C motif) ligand; FDR; false discovery rate; FF; fresh frozen; FFPE; formalin-fixed paraffin
Keywords: Desmoid tumor; Hemihyperplasia; Hemihypertrophy; Pancreas; CTNNB1
Keywords: AMH/AMHR = MIS; Anti-Müllerian Hormone/Receptor = Müllerian Inhibiting Substance; BPES; Blepharophimosis-Ptosis-Epicanthus inversus Syndrome; CTNNB1; Catenin (cadherin-associated protein) beta 1; CBX2; Chromobox2; Dpc; days post coitum; DSD; dis
Keywords: CTNNB1; Chicken; Oviduct; Estrogen; Ovary; Cancer;
Keywords: CTNNB1; hepatoblastoma; pathology; pediatric liver cancer classification
Keywords: A2M; alpha-2-macroglobulin; AMACR; alpha-methylacyl-CoA racemase; APOA1; apolipoprotein A-I; AR; androgen receptor; BCL2L1; BCL2-like 1; CAT; catalase; CCNA2; cyclin A2; CCND2; cyclin D2; CCNE1; cyclin E1; CEL; carboxyl ester lipase (bile salt-stimulated
CTNNB1 mutations in basal cell adenoma of the salivary gland
Keywords: Basal cell adenoma; CTNNB1; Beta catenin; Salivary glands;
Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo
Keywords: IFN-γ; Interferon gamma; Arg; Arginine; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; GCN2; general control nonderepressible 2; eIF2α; eukaryotic initiation factor 2; BMECs; bovine mammary epithelial cells; BC; breast cancer; R
Regulation and biological roles of the multifaceted miRNA-23b (MIR23B)
Keywords: miRNAs; MicroRNAs; C9orf3; Chromosome 9 Open Reading Frame 3; pri-miRNAs; primary miRNA; pre-miRNAs; precursor miRNAs; miRISC; miRNA-induced silencing complex; ECs; endothelial cells; VSMCs; vascular smooth muscle cells; ACTA2; smooth muscle α-actin; MYH
Overexpression of CTNNB1: Clinical implication in Chinese de novo acute myeloid leukemia
Keywords: AML; acute myeloid leukemia; BM; bone marrow; CR; complete remission; CN-AML; cytogenetically normal AML; LFS; leukemia free survival; OS; overall survival; RQ-PCR; real-time quantitative PCR; WHO; World Health Organization; CTNNB1; Expression; Prognosis;
Goat CTNNB1: mRNA expression profile of alternative splicing in testis and association analysis with litter size
Keywords: CTNNB1; Catenin beta 1; FSHR; follicle-stimulating hormone receptor; WGBS; whole-genome bisulfite sequencing; SRY; sex-determining region Y; AS; alternative Splicing; SNP; single nucleotide polymorphism; indel; insertion/deletion; SV; structural variation
Original articleMutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas
Keywords: Eyelid; Sebaceous carcinoma; CTNNB1; NRAS; BRAF; PIK3CA;
Beta-catenin and estrogen signaling collaborate to drive cyclin D1 expression in developing mouse prostate
Keywords: CCND1; (cyclin D1); CTNNB1; (beta-catenin); UGS; (urogenital sinus; Prostate development; Ccnd1; Estrogen; Ctnnb1; Androgen;
Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals
Keywords: CTNNB1; Intellectual disability; Microcephaly;
Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC
Keywords: BCCA; British Columbia Cancer Agency; CTNNB1; Catenin Beta 1; EGFR; Epidermal Growth Factor Receptor; FISH; Fluorescent in situ hybridization; HER 2; Human Epidermal Growth Factor Receptor 2; M+; Mutation-positive; NCI; National Cancer Institute; NSCLC; N
MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1
Keywords: MiR-330; IL-22; CTNNB1; Keratinocyte; Psoriasis;
Constitutive WNT/CTNNB1 activation triggers spermatogonial stem cell proliferation and germ cell depletion
Keywords: Gonocytes; Spermatogonia; CTNNB1; Canonical WNT signalling; Proliferation; Spermatogenesis;
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
Keywords: HCC; Tumor Progression; Benign; SHH; bex7,8HCA; β-catenin mutated hepatocellular adenoma in exon 7 or 8; bex7,8IHCA; β-catenin mutated inflammatory hepatocellular adenoma in exon 7 or 8; bex3IHCA; β-catenin mutated inflammatory hepatocellular adenoma i
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study
Keywords: Hepatoblastoma; CTNNB1; Wnt/β-catenin signaling; Comprehensive genomic profiling; Next-generation sequencing; Tumor mutation burden;
WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy
Keywords: BUN; blood urea nitrogen; Ccr; creatinine clearance rate; ChIP; chromatin immunoprecipitation; CTNNB1; β-catenin 1; DAPI; 4,6-diamidino-2-phenylindole; DCFH-DA; 2â², 7â²-dichlorodihydrofluorescein diacetate; DMSO; dimethyl sulphoxide; DN; diabetic neph
Paraquat inhibited differentiation in human neural progenitor cells (hNPCs) and down regulated miR-200a expression by targeting CTNNB1
Keywords: Paraquat; hNPCs; MicroRNA array; Neurotoxicity; CTNNB1; Differentiation;
Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics
Keywords: AC; adenylyl cyclase; ACTH; adrenocorticotropic hormone; AKAP; A-kinase anchor protein; AMP; 5â² adenosine monophosphate; AMPK; AMP-activated protein kinase; Arfgap1; ADP-ribosylation factor GTPase-activating protein 1; Arhgef2; Rho guanine nucleotide ex
Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication
Keywords: TLR3; HIV; Viral transactivation; LTR; NFκB; JNK; STAT1; Histone acetylation; Epigenetics; Human monocyte-derived macrophages; TZM-bl; U38 cells; AP-1; activator protein-1; B2M; beta-2-microglobulin; BCA; bicinchoninic acid; CAT; chloramphenicol acetyltr
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection
Keywords: CTNNB1; Hepatocellular carcinoma; Occult hepatitis B; TP53
NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling
Keywords: APC; adenomatous polyposis coli; BAC; bacterial artificial chromosome; CBC; crypt base columnar; Cp; crossing point; CRC; colorectal carcinoma; CTNNB1; the β-CATENIN gene; Dvl; dishevelled; EGFP; enhanced green fluorescent protein; EphB2; ephrin type-B r
Case ReportPaediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations
Keywords: Whole exome sequencing; ABCB11 mutations; Paediatric hepatocellular carcinoma; NFE2L2; CTNNB1;
Research ArticleThe genomic landscape of hepatoblastoma and their progenies with HCC-like features
Keywords: HB; hepatoblastoma; HCC; hepatocellular carcinoma; CTNNB1; beta catenin; NFE2L2; nuclear factor (erythroid-derived 2)-like 2; TERT; telomerase reverse-transcriptase; NQO1; NAD(P)H: quinone oxidoreductase 1; KEAP1; kelch-like ECH-associated protein 1; CUL3
GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type ★
Keywords: Gastric adenocarcinoma of the fundic gland type; CTNNB1; AXIN; APC; GNAS; KRAS; Mutation
Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components
Keywords: APC; adenomatosis polyposis coli; CTNNB1; β-catenin; DMSO; dimethylsulfoxide; CYP11A1; P450 cholesterol side chain cleavage; CYP19A1; cytochrome P450 aromatase; FBS; fetal bovine serum; Foxo; Forkhead box O; FZD; frizzled; GSK3β; glycogen synthase kinas
LGR5 is a biomarker for stratification of HER-2 positive breast cancer patients and personalized treatment
Keywords: AKT; v-akt murine thymoma viral oncogene; CTNNB1; catenin (cadherin-associated protein), beta 1; HER-2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2; IgG1; immunoglobulin G 1; LGR5; leucine-rich repeat containing G protein-coupled receptor 5;
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
Keywords: HCV, hepatitis C virus; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; TP53, tumor protein p53 gene; CTNNB1, human β-catenin gene; PIK3CA, phosphatidylinositol 3-kinase catalytic subunitTP53; CTNNB1; PIK3CA; Hepatocellular carcinoma; HCV; HBV; Ita
Beta-catenin (CTNNB1) induces Bmp expression in urogenital sinus epithelium and participates in prostatic bud initiation and patterning
Keywords: Prostate; Bmp; Ctnnb1; Urothelium; Urogenital sinus; Cloaca; Rectourethral fistula; Basal epithelium; Noggin; Androgen; Lower urogenital tract
Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
Keywords: CTNNB1; gp130; STAT3; GNASbHCA, β-catenin–mutated hepatocellular adenoma; FNH, focal nodular hyperplasia; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; H-HCA, HNF1A-mutated hepatocellular adenoma; IHCA, inflammatory hepatocellular adenoma; I
Frizzled7 as an emerging target for cancer therapy
Keywords: ALL; Acute lymphoblastic leukemia; APC; Adenomatous polyposis coli; CamKII; Calmodulin kinase II; Cthrc1; Collagen triple helix repeat containing protein; CK1; Caseine kinase 1; CTNNB1; β-catenin gene; CRD; Cysteine rich domain; CSC; Cancer stem cells; D
Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours
Keywords: Desmoid tumour; Aggressive fibromatosis; APC; β-Catenin; CTNNB1; FAP; Genetic counselling;
Towards the elucidation of the regulatory network guiding the insulin producing cells' differentiation
Keywords: NGN3 (NEUROG3); neurogenin3; ESCs; Embryonic Stem Cells; TFBS; Transcription Factor Binding Sites; TFs; Transcription Factors; AP4 (TFAP4); Activating enhancer-binding Protein 4 (Transcription Factor AP-4); WISP1; WNT-Induced Secreted Protein 1; CTGF; Con
Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032
Keywords: AK; adenylate kinase; AKT; v-akt murine thymoma viral oncogene homolog; ANOVA; analysis of variance; BCRP; breast cancer resistance protein; BRAF; v-raf murine sarcoma viral oncogene homolog B1; CCND1; cyclin D1; CRAF; v-raf-1 murine leukemia viral oncoge
ReviewCancer gene discovery in hepatocellular carcinoma
Keywords: Ang; angiopoietin; cIAP; cellular-inhibitor of apoptosis; CGH; comparative genomic hybridization; CTNNB1; catenin-beta 1; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; FGF; fibroblast growth factor; HGF; hepatocyte growth factor; H
Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma
Keywords: AKT; v-akt murine thymoma viral oncogene homolog; ANOVA; analysis of variance; ATCC; American Type Culture Collection; BRAF; v-raf murine sarcoma viral oncogene homolog B1; BRAFm; BRAF mutation; CKIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene
A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans
Keywords: APC; B-RAF; CTNNB1; Colorectal carcinomas; K-RAS; Microsatellite instability; Oncogenes; Tumour suppressor genes
Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning
Keywords: CRF; priming; prefrontal cortex; hippocampus; anxiety; fear; aCSF; artificial cerebrospinal fluid; Aplp1; amyloid beta (A4) precursor-like protein 1; CCK; cholecystokinin; cDNA; complementary DNA; CRF; corticotropin releasing factor; cRNA; complementary R
The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules
Keywords: FNH; focal nodular hyperplasia; HCA; hepatocellular adenoma; RT-PCR; reverse transcriptase polymerase chain reaction; GLUL; gene coding for glutamine synthetase; GS; glutamine synthetase; AAT1; alpha-1 antitrypsin deficiency; APC; adenomatosis polyposis c
IGFBP3 Promoter Methylation in Colorectal Cancer: Relationship with Microsatellite Instability, CpG Island Methylator Phenotype, p53
Keywords: Colon cancer; IGFBP3; methylation; CIMP; MSI; BAX; BCL2-associated X protein; CACNA1G; calcium channel; voltagedependent; T type alpha-1G subunit; CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, CIP1); CDKN2A; cyclin-dependent kinase inhibitor 2A (p16,
Lysosomal trafficking of β-catenin induced by the tea polyphenol epigallocatechin-3-gallate
Keywords: ALLN; N-acetyl-Leu-Leu-norleucinal; APC; adenomatous polyposis coli; CTNNB1; HUMAN gene coding for β-catenin; DAPI; 4â²,6-diamidine-2â²-phenylindole dihydrochloride; EGCG; epigallocatechin-3-gallate; E64; transepoxysuccinyl-L-leucylamido(4-guanido)buta